![Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer | SpringerLink Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10147-019-01485-z/MediaObjects/10147_2019_1485_Fig1_HTML.png)
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer | SpringerLink
![Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07186-5/MediaObjects/12885_2020_7186_Fig1_HTML.png)
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer
![Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group - The Lancet Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2052247457/2059676798/gr1.gif)
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group - The Lancet
![Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer - Gastroenterology Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5a51ce64-c52d-45bb-a636-1ee819a18695/gr1_lrg.jpg)
Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer - Gastroenterology
The College of American Pathologists Electronic Cancer Checklists (CAP eCC): Providing a Clear Guide to the New World of Cancer
![Performance of a web-based method for generating synoptic reports Renshaw MA, Renshaw SA, Mena-Allauca M, Carrion PP, Mei X, Narciandi A, Gould EW, Renshaw AA - J Pathol Inform Performance of a web-based method for generating synoptic reports Renshaw MA, Renshaw SA, Mena-Allauca M, Carrion PP, Mei X, Narciandi A, Gould EW, Renshaw AA - J Pathol Inform](https://www.jpathinformatics.org/articles/2017/8/1/images/JPatholInform_2017_8_1_13_201921_f2.jpg)
Performance of a web-based method for generating synoptic reports Renshaw MA, Renshaw SA, Mena-Allauca M, Carrion PP, Mei X, Narciandi A, Gould EW, Renshaw AA - J Pathol Inform
The Oncologist's Guide to Synoptic Reporting: A Primer - FullText - Oncology 2020, Vol. 98, No. 6 - Karger Publishers
![Connection and distinction of tumor regression grading systems of gastrointestinal cancer - ScienceDirect Connection and distinction of tumor regression grading systems of gastrointestinal cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0344033820306968-gr4.jpg)